CAS 1354825-58-3

N-[2-[4-Amino-3-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-pyridinecarboxamide

CAS: 1354825-58-3

Formula: C₂₂H₂₃N₇O

Purity: 99%

Color and Shape: Solid

Molecular weight: 401.4643

Ref: IN-DA009CKO

WEHI-345

Controlled Product

CAS: 1354825-58-3

Formula: C₂₂H₂₃N₇O

Color and Shape: Neat

Molecular weight: 401.464

Ref: TR-W498715

WEHI-345

CAS: 1354825-58-3

WEHI-345 is a synthetic compound that was designed using pharmacophore modeling techniques to interact with the kinase receptor. It has been shown to inhibit the production of pro-inflammatory cytokines in vitro, and also inhibits the proliferation of cells in vivo. This drug is being evaluated for its ability to treat inflammatory diseases such as asthma and rheumatoid arthritis.

Formula: C₂₂H₂₃N₇O

Purity: Min. 95%

Molecular weight: 401.46 g/mol

Ref: 3D-EEC82558

WEHI-345

CAS: 1354825-58-3

WEHI-345 is a potent and selective RIPK2 inhibitor which shows NOD signalling events yet prevents inflammatory cytokine production.

Formula: C₂₂H₂₃N₇O

Purity: >99.99%

Color and Shape: Solid

Molecular weight: 401.46

Ref: TM-T3997